Cargando…
Rapid COVID-19 Prognostic Blood Test for Disease Severity Using Epigenetic Immune System Biomarkers
OBJECTIVE: To develop a novel whole-blood epigenetic biomarker of immune system status, or EpiMarker, that would indicate whether a person with a recent COVID-19 diagnosis is at risk for severe symptoms including Acute Respiratory Distress Syndrome. METHODS: Using a novel methyl-sensitive restrictio...
Autores principales: | Marsh, Adam G., Anderson, G. Mark, Izdepski, Erich J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Delaware Academy of Medicine / Delaware Public Health Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389811/ https://www.ncbi.nlm.nih.gov/pubmed/34467104 http://dx.doi.org/10.32481/djph.2020.07.08 |
Ejemplares similares
-
Prognostic and Predictive Epigenetic Biomarkers in Oncology
por: Kamińska, Katarzyna, et al.
Publicado: (2018) -
Epigenetic DNA Methylation Profiling with MSRE: A Quantitative NGS Approach Using a Parkinson's Disease Test Case
por: Marsh, Adam G., et al.
Publicado: (2016) -
Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment
por: Wallace, Robert G., et al.
Publicado: (2016) -
Putting epigenetic biomarkers to the test for clinical trials
por: Justice, Jamie N, et al.
Publicado: (2020) -
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
por: Pidsley, Ruth, et al.
Publicado: (2022)